Discover how Delta-24-GREAT, a genetically engineered oncolytic virus, fights glioblastoma through direct cancer cell destruction and immune system activation.
Exploring how SLC7A11 overexpression in glioblastoma promotes cancer stem-cell like properties and creates therapeutic vulnerabilities